[
    {
        "drugresponse_id": "5141",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "4.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5142",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "4.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5143",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5144",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "4.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5145",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5146",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "4.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5147",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "5.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5167",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "5.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5168",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "4.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5185",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "4.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5198",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5199",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "4.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5209",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "4.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5216",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "5.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5217",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "5.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5218",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "4.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5228",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5235",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "5.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5236",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "4.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5239",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5240",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "4.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5241",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "5.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5244",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "5.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5252",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "5.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5255",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5258",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "4.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5270",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5271",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "4.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5272",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "5.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5279",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "5.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5281",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "4.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5282",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "4.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5288",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5295",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "5.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5298",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "5.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5299",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "4.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5303",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "4.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5317",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "4.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5332",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "5.96",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5337",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "4.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5339",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "5.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5340",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "4.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5342",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "4.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5354",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5368",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "5.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5369",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5371",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5374",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "4.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5375",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "5.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5397",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "5.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5405",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "A388",
        "VALUE": "5.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5412",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "5.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5421",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "4.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5423",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "4.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5424",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "4.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5428",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "4.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5437",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "4.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5438",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "4.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5444",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "4.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5454",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "4.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5455",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "5.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5456",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "4.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5457",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5458",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "4.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5460",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "4.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5463",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "4.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5464",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "5.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5465",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5466",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "4.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5467",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "4.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5468",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5469",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "4.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5470",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "4.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5471",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "5.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5472",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "4.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5473",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "4.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5474",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5475",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "4.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5476",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5477",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "5.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5478",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "5.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5479",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "4.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5480",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "5.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5481",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "5.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5482",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "4.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5483",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "5.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5485",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5489",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "5.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5494",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "4.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "COMPOUND_CLASS": "Kinase inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "399",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "420",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "6.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "421",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "465",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "466",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "467",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "485",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "488",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "7.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "498",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "6.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "509",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "510",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "516",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "529",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "532",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "537",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "6.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "550",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "5.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "563",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "6.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "568",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "6.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "570",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "583",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "601",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "618",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "630",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "6.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "642",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "6.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "646",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "654",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "655",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "671",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "5.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "672",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "5.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "673",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "6.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "674",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "675",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "688",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "689",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "690",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "5.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "691",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "692",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "693",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "694",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "695",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "696",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "701",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "399",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "420",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "6.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "421",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "465",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "466",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "467",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "485",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "488",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "7.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "498",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "6.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "509",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "510",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "516",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "529",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "532",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "537",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "6.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "550",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "5.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "563",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "6.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "568",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "6.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "570",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "583",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "601",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "618",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "630",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "6.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "642",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "6.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "646",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "654",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "655",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "671",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "5.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "672",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "5.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "673",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "6.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "674",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "675",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "688",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "689",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "690",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "5.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "691",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "692",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "693",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "694",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "695",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "696",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "701",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "399",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "420",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "6.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "421",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "465",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "466",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "467",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "485",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "488",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "7.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "498",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "6.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "509",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "510",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "516",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "529",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "532",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "537",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "6.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "550",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "5.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "563",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "6.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "568",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "6.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "570",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "583",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "601",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "618",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "630",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "6.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "642",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "6.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "646",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "654",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "655",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "671",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "5.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "672",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "5.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "673",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "6.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "674",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "675",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "688",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "689",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "690",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "5.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "691",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "692",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "693",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "694",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "695",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "696",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "701",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1950",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1951",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1952",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "5.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1953",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1954",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GB-1",
        "VALUE": "7.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1227",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1977",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1978",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1994",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "6.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2007",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "7.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2008",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "7.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2018",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "7.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2025",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2026",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2027",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2037",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2044",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "7.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2045",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "7.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2048",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SNB75",
        "VALUE": "7.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1706",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2049",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "7.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2060",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2063",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "5.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2066",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2079",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "7.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2080",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "7.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2087",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HT-144",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0318",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2090",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IST-MEL1",
        "VALUE": "7.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1308",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2103",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2106",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2107",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "5.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2111",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "7.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2125",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "6.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2139",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "7.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2144",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2146",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "7.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2147",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2161",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "7.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2176",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF126",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1688",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2179",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2182",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2205",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2212",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A388",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1063",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2219",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2227",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "7.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2229",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2230",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "5.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2234",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2243",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2244",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2250",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "7.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2261",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "7.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2262",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "7.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2263",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "6.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2264",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2266",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "CP67-MEL",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1145",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2269",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2270",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2271",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES6",
        "VALUE": "7.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1202",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2272",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "7.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2273",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2274",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "4.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2275",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-1",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1208",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2276",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "7.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2277",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-16",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1212",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2278",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "5.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2279",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "7.22",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2280",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2281",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "5.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2282",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2283",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2284",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2285",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2286",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2287",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2289",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2292",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "2297",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "7.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Peripheral Angiopathy in Diseases Classified Elsewhere",
        "Phase": "3"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "399",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "420",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "6.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "421",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "465",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "466",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "467",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "485",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "6.81",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "488",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "7.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "495",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-800",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1135",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "498",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "6.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "501",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "DJM-1",
        "VALUE": "6.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1172",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Skin Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "509",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "510",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GOTO",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1234",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "516",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "529",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KINGS-1",
        "VALUE": "7.8",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1328",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "532",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-42",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0378",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "533",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H-EMC-SS",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1238",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Chondrosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "537",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YN",
        "VALUE": "6.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1341",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "550",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "5.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "563",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "6.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "568",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NH-12",
        "VALUE": "6.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1605",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "570",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "no-11",
        "VALUE": "7.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3076",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "583",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ONS-76",
        "VALUE": "6.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1624",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "595",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SH-4",
        "VALUE": "8.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1692",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "597",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SJSA-1",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1697",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Osteosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "600",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-1",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0068",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "601",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "7.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "618",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CHP-126",
        "VALUE": "6.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1123",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "630",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TGW",
        "VALUE": "6.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1771",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Adrenal Gland Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "639",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "A101D",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1057",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "641",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "GAK",
        "VALUE": "6.97",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1225",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "642",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AM-38",
        "VALUE": "6.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1070",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "646",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAS-1",
        "VALUE": "6.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1117",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "654",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KNS-81-FD",
        "VALUE": "7.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1336",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "655",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-RT-BM-1",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1339",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "661",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MMAc-SF",
        "VALUE": "6.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1420",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "671",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "5.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "672",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-247MG",
        "VALUE": "5.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1153",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "673",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-263MG",
        "VALUE": "6.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1154",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "674",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "675",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "D-502MG",
        "VALUE": "5.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1162",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "679",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES8",
        "VALUE": "7.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1204",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "680",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES4",
        "VALUE": "9.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1200",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "681",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES1",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1198",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "682",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-3",
        "VALUE": "6.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1216",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "683",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-12",
        "VALUE": "7.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1210",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "684",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-18",
        "VALUE": "6.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "685",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-13",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1211",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "686",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-22",
        "VALUE": "6.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1214",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "687",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-24",
        "VALUE": "6.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1215",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "688",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LAN-6",
        "VALUE": "6.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1363",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "689",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB10",
        "VALUE": "6.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1441",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "690",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB6",
        "VALUE": "5.94",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8823",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "691",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB7",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8824",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "692",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "6.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "693",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "6.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "694",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "7.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "695",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "6.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "696",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB1",
        "VALUE": "7.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1440",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "698",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ2-MEL",
        "VALUE": "7.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1435",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "701",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB(TU)1-10",
        "VALUE": "6.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3041",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "706",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TC-71",
        "VALUE": "6.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2213",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "394",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES5",
        "VALUE": "5.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1201",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "395",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "ES7",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1203",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "396",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "EW-11",
        "VALUE": "6.92",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1209",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "397",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-ES-1",
        "VALUE": "6.99",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0627",
        "ONCOTREE_LINEAGE": "Bone",
        "ONCOTREE_PRIMARY_DISEASE": "Ewing's Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "398",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "COLO-829",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1137",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "399",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "6.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "420",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-DZ",
        "VALUE": "6.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1701",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "421",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-N-FI",
        "VALUE": "6.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1702",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "437",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CP66-MEL",
        "VALUE": "5.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1144",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "448",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB2518-MEL",
        "VALUE": "5.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1366",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "449",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LB373-MEL-D",
        "VALUE": "6.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1367",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "458",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MZ7-mel",
        "VALUE": "6.75",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1436",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "465",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "BE2-M17",
        "VALUE": "6.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0167",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "466",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "6.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "467",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SIMA",
        "VALUE": "5.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1695",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "475",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-MEL-2",
        "VALUE": "6.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0069",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "481",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "LOXIMVI",
        "VALUE": "6.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1381",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Amelanotic Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "482",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "UACC-257",
        "VALUE": "6.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1779",
        "ONCOTREE_LINEAGE": "Skin",
        "ONCOTREE_PRIMARY_DISEASE": "Melanoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Hypertensive Disease",
        "Phase": "2"
    }
]